/CTTH

CTTH Stock - CTT Pharmaceutical Holdings, Inc.

Q: What is the analyst price target for CTTH?

Analyst price target information is not currently available for CTTH.

Q: What is CTTH's market cap?

Market capitalization information is not currently available for CTTH.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.05-1.92%

$0.00 (-1.92%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.06

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for CTTH

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.40

52W High$0.15

52W Low$0.02

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	$-6,398	$-6,398	$-6,398	N/A	N/A
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Income	$-250,000	$-42,090	$-109,000	$-148,000	$-584,000
Net Income	$-210,000	$-42,215	$-53,448	$-133,000	$-586,000
Net Margin	N/A	N/A	N/A	N/A	N/A
EPS	$-0.00	$-0.00	$-0.00	$-0.00	$-0.01

Company Overview

CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered wafer, an orally administrable wafer comprising at least one physiologically acceptable film forming agent. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. The company is based in Ottawa, Canada.

Visit Website

Frequently Asked Questions about CTTH

What is CTTH's current stock price?

CTT Pharmaceutical Holdings, Inc. (CTTH) is currently trading at $0.05 per share. The stock has moved -1.92% today.

What is the analyst price target for CTTH?

No analyst price targets are currently available for this stock.

What sector is CTT Pharmaceutical Holdings, Inc. in?

CTT Pharmaceutical Holdings, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is CTTH's market cap?

CTT Pharmaceutical Holdings, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does CTTH pay dividends?

No, CTT Pharmaceutical Holdings, Inc. does not currently pay a dividend to shareholders.